AzTrials
AzTrials

Self-Directed LearningCHAT-MSNCT06276049

ChatGPT Helping Advance Training for Medical Students: A Study on Self-Directed Learning Enhancement

A study testing custom GPT supported self-directed learning in people with Self-Directed Learning and Artificial Intelligence, run by Wang Shalong at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate the effect of LearnGuide, a custom GPT developed with ChatGPT for supporting self-directed learning (SDL) in medical students. The main questions it aims to answer are: How does LearnGuide influence SDL skills among medical students? Can LearnGuide improve critical… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
custom GPT supported self-directed learning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
103 participants
Where
1 siteChina
Study dates
25 Nov 2023to 15 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Undergraduate and postgraduate students studying at the Second Xiangya Hospital
  • with access to ChatGPT

Who cannot join

  • utilization of large language models for learning assistance more than once weekly for a period exceeding 2 months.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Department of Geriatirc Surgery

    Changsha, Hunan, 410011

Other trials in China

About this study

Official title: Enhancement of Self-Directed Learning Through Custom GPT's AI Facilitation Among Medical Students: A Open-label, Randomized Controlled Trial

The goal of this clinical trial is to evaluate the effect of LearnGuide, a custom GPT developed with ChatGPT for supporting self-directed learning (SDL) in medical students. The main questions it aims to answer are:

How does LearnGuide influence SDL skills among medical students? Can LearnGuide improve critical thinking and learning flow as measured by Cornell Critical Thinking Test (CCTT) Level Z score and Global Flow Score (GFS)?

Read more

Participants will:

Undergo a two-hour introduction to LearnGuide. Engage in 12 weeks of SDL task-based training with LearnGuide\'s support.

If there is a comparison group: Researchers will compare the group utilizing LearnGuide for SDL and the group without this tool to see if there is a significant difference in SDL skills, critical thinking, and learning flow experiences.

Being tested
custom GPT supported self-directed learning
Keywords
self-directed learning, Artificial Intelligence, Medical Education, ChatGPT, large language model

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • custom GPT supported self-directed learningOther

    The intervention in our study involved a LearnGuide utilization guide course along with a 12-week integrated training program that incorporated LearnGuide. In the first two-hour session, instructional staff introduced LearnGuide through a hands-on demonstration, teaching students how to use ChatGPT effectively by crafting high-quality prompts. The team emphasized LearnGuide's role as an "AI facilitator" in self-directed learning (SDL). Following the introduction, students were assigned various tasks including online learning, literature reviews, case analyses, and Problem-Based Learning (PBL) activities. Over the 12-week SDL phase with LearnGuide, students were required to complete at least one of these tasks weekly. This setup allowed students to consult mentors for any LearnGuide-related questions, enhancing their learning experience.

Study groups in NCT06276049
Study groupRoleWhat they receive
Intervention groupExperimentalEngage in 12 weeks of SDL task-based training with LearnGuide\'s support.
Receives: Other: custom GPT supported self-directed learning
control groupNo interventionthe control group engaged in SDL task-based training without the support of LearnGuide or any similar artificial intelligence (AI) assistance.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-Directed Learning Scale

    Utilizing a five-point Likert scale across ten items, assesses learning autonomy in adolescents and adults. Anchored in Brockett's framework, it quantifies learners' independent learning inclination, exhibiting robust internal consistency and validity

    Measured: at 6 ,12 and 14 weeks

Secondary outcomes (2)
  1. Cornell Critical Thinking Test (CCTT) Level Z

    The CCTT Level Z measures cognitive abilities in students beyond 11th grade with 52 multiple-choice questions across six domains based on the Ennis and Millman Theory, including deductive and inductive reasoning, semantic analysis, credibility assessment, experimental planning, and assumption identification

    Measured: at 6 ,12 and 14 weeks

  2. Flow Short Scale

    The Flow Short Scale (FSS), a condensed form of the Flow State Scale, features ten items on a 7-point scale to assess the flow experience across various activities, from sports to gaming. Its concise yet comprehensive format has made it widely used for evaluating flow experiences in diverse settings

    Measured: at 6 and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2024
  2. Study start25 Nov 2023
  3. Primary completion18 Mar 2024
  4. Study completion15 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
103 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06276049
Sponsor's protocol ID
DGETRRP2023-54
Acronym
CHAT-MS
Status last verified
May 2024
First submitted
17 Feb 2024
Last updated
16 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: In our study, the decision regarding the sharing of individual participant data (IPD) has not yet been made due to ongoing considerations about privacy, consent, and data protection. We are currently evaluating the ethical implications and ensuring compliance with relevant data protection regulations before making a decision. Additionally, we aim to assess the feasibility of anonymizing IPD in a manner that maintains the integrity and utility of the data for potential future research. Our priority is to safeguard participant confidentiality and respect their consent preferences, while also considering the value of data sharing for advancing scientific knowledge. Further discussions and consultations with stakeholders are planned to reach a well-informed decision.

Publications

  • Shalong W, Yi Z, Bin Z, Ganglei L, Jinyu Z, Yanwen Z, Zequn Z, Lianwen Y, Feng R. Enhancing self-directed learning with custom GPT AI facilitation among medical students: A randomized controlled trial. Med Teach. 2025 Jul;47(7):1126-1133. doi: 10.1080/0142159X.2024.2413023. Epub 2024 Oct 19.

    PubMed 39425996

Questions about this trial

What is this clinical trial studying?

A study testing custom GPT supported self-directed learning in people with Self-Directed Learning and Artificial Intelligence, run by Wang Shalong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-Directed Learning Scale (time frame: at 6 ,12 and 14 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06276049, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in